Lgt Fund Management CO Ltd. Dexcom Inc Transaction History

Lgt Fund Management CO Ltd.

  • $952 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
BUY
$67.99 - $132.89 $2.35 Million - $4.59 Million
34,541 Added 1203.52%
37,411 $2.79 Million
Q1 2022

May 11, 2022
BUY
$94.08 - $130.2 $222,969 - $308,574
2,370 Added 474.0%
2,870 $1.53 Million
Q4 2021

May 03, 2022
BUY
$129.87 - $162.82 $64,935 - $81,410
500 New
500 $268,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Lgt Fund Management CO Ltd. Portfolio

Follow Lgt Fund Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Fund Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Lgt Fund Management CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email